Correlation Between 4D Molecular and Marker Therapeutics
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Marker Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Marker Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Marker Therapeutics, you can compare the effects of market volatilities on 4D Molecular and Marker Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Marker Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Marker Therapeutics.
Diversification Opportunities for 4D Molecular and Marker Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between FDMT and Marker is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Marker Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marker Therapeutics and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Marker Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marker Therapeutics has no effect on the direction of 4D Molecular i.e., 4D Molecular and Marker Therapeutics go up and down completely randomly.
Pair Corralation between 4D Molecular and Marker Therapeutics
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to generate 0.71 times more return on investment than Marker Therapeutics. However, 4D Molecular Therapeutics is 1.41 times less risky than Marker Therapeutics. It trades about -0.15 of its potential returns per unit of risk. Marker Therapeutics is currently generating about -0.12 per unit of risk. If you would invest 787.00 in 4D Molecular Therapeutics on November 27, 2024 and sell it today you would lose (335.00) from holding 4D Molecular Therapeutics or give up 42.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. Marker Therapeutics
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| Marker Therapeutics |
4D Molecular and Marker Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and Marker Therapeutics
The main advantage of trading using opposite 4D Molecular and Marker Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Marker Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marker Therapeutics will offset losses from the drop in Marker Therapeutics' long position.| 4D Molecular vs. Revolution Medicines | 4D Molecular vs. Black Diamond Therapeutics | 4D Molecular vs. Passage Bio | 4D Molecular vs. Century Therapeutics |
| Marker Therapeutics vs. Exicure | Marker Therapeutics vs. Protagenic Therapeutics | Marker Therapeutics vs. Pmv Pharmaceuticals | Marker Therapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |